Guest guest Posted August 26, 2003 Report Share Posted August 26, 2003 ----- Original Message ----- From: Sybil Goldrich Sent: Tuesday, August 26, 2003 1:44 PM Subject: ACTION ALERT ACTION ALERT Manufacturer Announces the Food and Drug Administration (FDA) Will Review Silicone Breast Implant Clinical Data In October! WHAT THIS MEANS: The FDA could approve silicone breast implants based only on short-term data despite the fact that current research demonstrates the onset of complications (including rupture, silicone migration and systemic illness symptoms and diseases) occur in a range of 7 to 10 years. WE NEED YOUR HELP! It is critical that the FDA hear from women on the need for longer clinical trials. Data collected after silicone breast implants are approved, through post-market surveillance, or data collected from the ongoing and loosely monitored “adjunct” study can NOT replace rigorous clinical trials. WHAT TO DO TO TAKE ACTION: Go to the www.commandtrust.org website. Click on the “Click here to take action” link in the lower left corner of the screen. (You will be taken to an action alert page with directions to send an email.) By simply filling in your home address and personalizing a pre-prepared letter you will be able to send an email to your Senators, your Member of Congress and key FDA officials with a single click of the button. TELL A FRIEND! Once approved there is virtually no mechanism for the FDA to control the use of silicone breast implants. We have a chance to slow the process NOW, but we need your support – and YOUR EMAILS to FDA! Please tell a friend or family member to do the same. Every single email counts! Command Trust Network Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.